| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 31-Mar-09 | 27-Dec-08 | | Total Revenue | 323,205 | 230,528 | 285,231 | 463,322 | | Cost of Revenue | 284,707 | 194,591 | 259,360 | 414,312 | | | Gross Profit | 38,498 | 35,937 | 25,871 | 49,010 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,040 | 16,780 | 15,740 | 20,489 | | Non Recurring |
-
|
-
| 856 | 950 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,458 | 19,157 | 9,275 | 27,571 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 14 |
-
| | Earnings Before Interest And Taxes | 22,458 | 19,157 | 9,289 | 27,571 | | Interest Expense | 2,546 | 2,637 | 3,059 | 3,695 | | Income Before Tax | 19,912 | 16,520 | 6,230 | 23,876 | | Income Tax Expense | 7,487 | 5,434 | 3,589 | 10,040 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,425 | 11,086 | 2,641 | 13,836 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,425 | 11,086 | 2,641 | 13,836 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| 867 | | | Net Income Applicable To Common Shares | $6,546 | $11,086 | $2,641 | $14,703 |
|
0.20% Nasdaq 
Income Statement
